{
    "2021-08-19": [
        [
            {
                "time": "",
                "original_text": "中泰证券维持康泰生物买入评级：老牌疫苗企业厚积薄发，在研产品陆续进入收获期",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "疫苗",
                        "买入评级",
                        "在研产品",
                        "收获期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}